C. Cather

发表

Implementation and fidelity assessment of the NAVIGATE treatment program for first episode psychosis in a multi-site study

R. Rosenheck, D. Penn, D. Robinson, 2019, Schizophrenia Research.

The effects of reduced nicotine content cigarettes in smokers with mood or anxiety disorders: a double-blind randomized trial

C. Lester, A. Evins, J. Muscat, 2022, medRxiv.

Improved Glycemic Control in Adults With Serious Mental Illness and Diabetes With a Behavioral and Educational Intervention.

A. Thorndike, D. Wexler, O. Freudenreich, 2020, Psychiatric services.

A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders.

Haiyi Xie, K. Mueser, Rosemarie Wolfe, 2013, Schizophrenia bulletin.

An exploratory open‐label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia

D. Goff, O. Freudenreich, L. Kunkel, 2006, Acta psychiatrica Scandinavica.

Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.

D. Goff, O. Freudenreich, A. Evins, 2005, The Journal of clinical psychiatry.

Supportive therapy for schizophrenia: possible mechanisms and implications for adjunctive psychosocial treatments.

N. Tarrier, D. Penn, M. Otto, 2004, Schizophrenia bulletin.

Demographic and clinical correlates of substance use disorders in first episode psychosis

R. Rosenheck, D. Penn, C. Correll, 2017, Schizophrenia Research.

A double‐blind, placebo‐controlled trial of sibutramine for clozapine‐associated weight gain

O. Freudenreich, A. Evins, D. Henderson, 2007, Acta psychiatrica Scandinavica.

A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.

D. Goff, O. Freudenreich, A. Evins, 2005, American Journal of Psychiatry.

Air pollution and hippocampal atrophy in first episode schizophrenia

B. Ardekani, D. Goff, E. Petkova, 2020, Schizophrenia Research.

Patient Experience and Predictors of Improvement in a Group Behavioral and Educational Intervention for Individuals With Diabetes and Serious Mental Illness: Mixed Methods Case Study

Gladys N. Pachas, A. Evins, G. Pachas, 2021, Journal of participatory medicine.

Patient Experience and Predictors of Improvement in a Group Behavioral and Educational Intervention for Individuals With Diabetes and Serious Mental Illness: Mixed Methods Case Study (Preprint)

A. Evins, G. Pachas, K. Schnitzer, 2020 .

Antisocial personality disorder in people with co-occurring severe mental illness and substance use disorders: clinical, functional, and family relationship correlates

K. Mueser, Rosemarie Wolfe, R. Clark, 2012, Psychosis.

Ziprasidone as an adjuvant for clozapine‐ or olanzapine‐associated medical morbidity in chronic schizophrenia

D. Goff, O. Freudenreich, A. Evins, 2009, Human psychopharmacology.

Citalopram in first episode schizophrenia: The DECIFER trial

B. Ardekani, D. Goff, A. Troxel, 2019, Schizophrenia Research.

Demographic and clinical correlates of substance use disorders in first episode psychosis

R. Rosenheck, D. Penn, C. Correll, 2017, Schizophrenia Research.

A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders.

Haiyi Xie, K. Mueser, Rosemarie Wolfe, 2013, Schizophrenia bulletin.

Implementation and fidelity assessment of the NAVIGATE treatment program for first episode psychosis in a multi-site study

R. Rosenheck, D. Penn, D. Robinson, 2019, Schizophrenia Research.